Progress of Ring Finger Protein 213 Gene-related Cerebrovascular Disease

doi:10.3969/j.issn.1673-5765.2020.02.018

Abstract

Abstract:

Intracranial major arterial stenosis / occlusion ( ICASO) is one of the most common causes of ischemic stroke in China. Previous studies have suggested that ICASO is similar to moyamoya disease in involved blood vessels and ethnic differences. The ring finger protein 213 (RNF213) gene is known to be the first reported susceptibility gene to moyamoya disease. Recently, several teams have reported that RNF213 gene is also associated with ICASO, atherosclerotic ischemic stroke and intracranial aneurysms, which suggests that RNF213 gene may be closely related to the occurrence and development of cerebrovascular diseases. So this paper summarized the structure, function, gene polymorphism of RNF213 and its correlation with cerebrovascular diseases by reviewing the relevant literature at home and abroad.

Key words: Ring finger protein 213 gene; Moyamoya disease; Intracranial artery stenosis;Ischemic stroke; Gene polymorphism

摘要：

颅内大动脉狭窄/闭塞（intracranial major artery stenosis／occlusion，ICASO）是我国缺血性卒中最常见病因之一。既往研究提示其与烟雾病在受累血管分布、种族差异性等方面具有相似性。环指蛋白213（ring finger protein 213，RNF213）基因是烟雾病的易感基因。研究发现该基因与ICASO、大动脉粥样硬化性缺血性卒中、颅内动脉瘤同样具有相关性，提示RNF213基因可能与脑血管病发生、发展存在密切的联系。本文旨在通过回顾国内外相关文献，就RNF213 结构、功能、基因多态性及与脑血管病相关性等问题进行概述。

关键词: RNF213基因; 烟雾病; 颅内动脉狭窄; 缺血性卒中; 基因多态性

ZHOU Hong-Yu, SUO Yue, CHEN Wei-Qi, WANG Yong-Jun. Progress of Ring Finger Protein 213 Gene-related Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2020, 15(02): 195-201.

周宏宇，索阅，陈玮琪，王拥军. RNF213 基因相关脑血管病研究进展[J]. 中国卒中杂志, 2020, 15(02): 195-201.

References

[1] CHIMOWITZ M，LYNN M，DERDEYN C，et

al. Stenting versus aggressive medical therapy for

intracranial arterial stenosis[J]. N Engl J Med，2011，

11（365）：993-1003.

[2] KAMADA F，AOKI Y，NARISAWA A，et al. A

genome-wide association study identifies RNF213

as the first moyamoya disease gene[J]. J Hum Genet，

2011，56（1）：34-40.

[3] MIYAWAKI S，IMAI H，TAKAYANAGI S，et

al. Identification of a genetic variant common to

moyamoya disease and intracranial major artery

stenosis/occlusion[J]. Stroke，2012，43（12）：3371-

3374.

[4] MORITO D，NISHIKAWA K，HOSEKI J，et al.

Moyamoya disease-associated protein mysterin/

RNF213 is a novel AAA+ ATPase，which

dynamically changes its oligomeric state[J/OL].

Sci Rep，2014，4：4442[2019-10-13]. https：//doi.

org/10.1038/srep04442.[5] JOAZEIRO C，WEISSMAN A. RING finger proteins：

mediators of ubiquitin ligase activity[J]. Cell，2000，

102（5）：549-552.

[6] SAUER R T，BAKER T A. AAA+ proteases：ATPfueled

machines of protein destruction[J]. Annu Rev

Biochem，2011，80：587-612.

[7] LEE S，SOWA M E，WATANABE Y H，et al. The

structure of ClpB：a molecular chaperone that

rescues proteins from an aggregated state[J]. Cell，

2003，2（115）：229-240.

[8] SUZUKI J，TAKAKU A. Cerebrovascular

“moyamoya”disease. Disease showing abnormal

net-like vessels in base of brain[J]. Arch Neurol，

1969，20（3）：288-299.

[9] SCOTT R M，SMITH E R. Moyamoya disease and

moyamoya syndrome[J]. N Engl J Med，2009，360

（12）：1226-1237.

[10] KURODA S，HOUKIN K. Moyamoya disease：

current concepts and future perspectives[J]. Lancet

Neurol，2008，7（11）：1056-1066.

[11] MINEHARU Y，TAKENAKA K，YAMAKAWA

H，et al. Inheritance pattern of familial moyamoya

disease：autosomal dominant mode and genomic

imprinting[J]. J Neurol Neurosurg Psychiatry，2006，

77（9）：1025-1029.

[12] LIU W，MORITO D，TAKASHIMA S，et al.

Identification of RNF213 as a susceptibility gene

for moyamoya disease and its possible role in

vascular development[J/OL]. PLoS One，2011，6（7）：

e22542[2019-10-13]. https：//doi.org/10.1371/journal.

pone.0022542.

[13] WU Z，JIANG H，ZHANG L，et al. Molecular

analysis of RNF213 gene for moyamoya disease in

the Chinese Han population[J/OL]. PLoS One，2012，

7（10）：e48179[2019-10-13]. https：//doi.org/10.1371/

journal.pone.0048179.

[14] MIYATAKE S，MIYAKE N，TOUHO H，et al.

Homozygous c. 14576G>A variant of RNF213

predicts early-onset and severe form of moyamoya

disease[J]. Neurology，2012，78（11）：803-810.

[15] CECCHI A C，GUO D，REN Z，et al. RNF213 rare

variants in an ethnically diverse population with

moyamoya disease[J]. Stroke，2014，45（11）：3200-

3207.

[16] WANG Y，ZHAO X，LIU L，et al. Prevalence and

outcomes of symptomatic intracranial large artery

stenoses and occlusions in China：the Chinese

Intracranial Atherosclerosis（CICAS）Study[J].

Stroke，2014，45（3）：663-669.

[17] PU Y，LIU L，WANG Y，et al. Geographic and

sex difference in the distribution of intracranial

atherosclerosis in China[J]. Stroke，2013，44（8）：

2109-2114.

[18] OJHA R，HUANG D，AN H，et al. Distribution

of ischemic infarction and stenosis of intra- and

extracranial arteries in young Chinese patients with

ischemic stroke[J/OL]. BMC Cardiovasc Disord，

2015，15：158[2019-10-13]. https：//doi.org/10.1186/

s12872-015-0147-5.

[19] PARK M G，SHIN J H，LEE S W，et al. RNF213

rs112735431 polymorphism in intracranial artery

steno-occlusive disease and moyamoya disease in

Koreans[J]. J Neurol Sci，2017，375：331-334.

[20] XUE S，CHENG W，WANG W，et al. The

association between the ring finger protein 213

gene R4810K variant and intracranial major artery

stenosis/occlusion in the Han Chinese population

and high-resolution magnetic resonance imaging

findings[J]. Brain Circ，2018，4（1）：33-39.

[21] ZHANG T，GUO C，LIAO X，et al. Genetic analysis

of RNF213 p. R4810K variant in non-moyamoya

intracranial artery stenosis/occlusion disease in a

Chinese population[J/OL]. Environ Health Prev Med，

2017，22：41[2019-10-13]. https：//doi.org/10.1186/

s12199-017-0649-0.

[22] ZHANG Q，YU L，GE P，et al. Association of ring

finger protein 213 gene p.R4810k polymorphism

with intracranial major artery stenosis/occlusion[J]. J

Stroke Cerebrovasc Dis，2018，27（6）：1556-1564.

[23] WANG W，JIANG B，SUN H，et al. Prevalence，

incidence，and mortality of stroke in China：results

from a nationwide population-based survey of

480 687 adults[J]. Circulation，2017，8（135）：759-

771.

[24] OKAZAKI S，MORIMOTO T，KAMATANI

Y，et al. Moyamoya disease susceptibility variant

RNF213 p.R4810K increases the risk of ischemic

stroke attributable to large-artery atherosclerosis[J].

Circulation，2019，139（2）：295-298.

[25] KAMIMURA T，OKAZAKI S，MORIMOTO T，et

al. Prevalence of RNF213 p.R4810K variant in earlyonset

stroke with intracranial arterial stenosis[J].

Stroke，2019，50（6）：1561-1563.

[26] LIU Y，WU X，FAN Z，et al. Development of

atherosclerotic-moyamoya syndrome with genetic

variant of RNF213 p.R4810K and p.T1727M：a case

report[J]. Clin Neurol Neurosurg，2018，168：163-

166.

[27] FROSEN J. Smooth muscle cells and the

formation，degeneration，and rupture of saccular

intracranial aneurysm wall--a review of current

pathophysiological knowledge[J]. Transl Stroke Res，2014，5（3）：347-356.

[28] RUIGROK Y M，RINKEL G J. Genetics of

intracranial aneurysms[J]. Stroke，2008，39（3）：

1049-1055.

[29] CARANCI F，BRIGANTI F，CIRILLO L，et

al. Epidemiology and genetics of intracranial

aneurysms[J]. Eur J Radiol，2013，82（10）：1598-

1605.

[30] FUKUSHIMA Y，MIYAWAKI S，INOUE T，et

al. Repeated de novo aneurysm formation after

anastomotic surgery：potential risk of genetic variant

RNF213 c.14576G>A[J/OL]. Surg Neurol Int，2015，

6：41[2019-10-13]. https：//doi.org/10.4103/2152-

7806.153709.

[31] ZHOU S，AMBALAVANAN A，ROCHEFORT

D，et al. RNF213 is associated with intracranial

aneurysms in the French-Canadian population[J].

Am J Hum Genet，2016，99（5）：1072-1085.

[32] HITOMI T，HABU T，KOBAYASHI H，et al. The

moyamoya disease susceptibility variant RNF213

R4810K（rs112735431）induces genomic instability

by mitotic abnormality[J]. Biochem Biophys Res

Commun，2013，439（4）：419-426.

[33] SONOBE S，FUJIMURA M，NIIZUMA K，et al.

Temporal profile of the vascular anatomy evaluated

by 9.4-T magnetic resonance angiography and

histopathological analysis in mice lacking RNF213：

a susceptibility gene for moyamoya disease[J]. Brain

Res，2014，1552：64-71.

[34] SONOBE S，FUJIMURA M，NIIZUMA K，et

al. Increased vascular MMP-9 in mice lacking

RNF213：moyamoya disease susceptibility gene[J].

Neuroreport，2014，25（18）：1442-1446.

[35] ITO A，FUJIMURA M，NIIZUMA K，et al.

Enhanced post-ischemic angiogenesis in mice

lacking RNF213；a susceptibility gene for moyamoya

disease[J]. Brain Res，2015，1594：310-320.

[36] KONG Y W，FERLAND-MCCOLLOUGH

D，JACKSON T J，et al. microRNAs in cancer

management[J/OL]. Lancet Oncol，2012，13（6）：

e249-e258[2019-10-13]. https：//doi.org/10.1016/

S1470-2045（12）70073-6.

[37] DAI D，LU Q，HUANG Q，et al. Serum miRNA

signature in Moyamoya disease[J/OL]. PLoS One，

2014，9（8）：e102382[2019-10-13]. https：//doi.

org/10.1371/journal.pone.0102382.

[38] KOBAYASHI H，MATSUDA Y，HITOMI T，et

al. Biochemical and functional characterization

of RNF213（mysterin）R4810K，a susceptibility

mutation of moyamoya disease，in angiogenesis in

vitro and in vivo[J/OL]. J Am Heart Assoc，2015，4

（7）：e002146[2019-10-13]. https：//doi.org/10.1161/

JAHA.115.002146.

[39] OHKUBO K，SAKAI Y，INOUE H，et al.

Moyamoya disease susceptibility gene RNF213 links

inflammatory and angiogenic signals in endothelial

cells[J/OL]. Sci Rep，2015，5：13191[2019-10-13].

https：//doi.org/10.1038/srep13191.